http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1761551-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d3fa61f786878fae97455d646b04b4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35655ff6b59f5aac079a582b42ccdf87
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
filingDate 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e304320d13317ceb1771e813820a462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec3338d2e915d754a561b1cee8b7e82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d211f4d3cd64fcd8863a5df3ee8dfc17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_669171d0693478e0cc2b57a53c4a913a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9056ea81dd9cb8b5d3595e115f54daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09492db2c1787d4caaab86e9702363ad
publicationDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1761551-B1
titleOfInvention Gemcitabine derivatives nanoparticles
abstract The invention concerns a 2',2'-difluoro-2'-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing said compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8956613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540410-B2
priorityDate 2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136044168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694C1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1QFS3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694C0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90767053
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7YR25
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694B9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694B8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7YR24
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCR4GK03
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1YJY6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7YR23
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694C5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694C4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226771973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46705350
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694C2
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2029523
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4BZK2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3MHR2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43346
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226774756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395395
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9HC16
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66690978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243254203
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2029523
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27707
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33262
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446773
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID541538
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79127
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39429
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5ZMF3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18414901
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID936793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694B7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ694B6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226599064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43828
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID530642

Total number of triples: 87.